Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant SOX for Elderly Gastric Cancer
NCT04677673Phase 3Not yet recruiting
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Reversible Covalent Inhibitors, DNA Intercalators/Alkylators, Allosteric Modulators
01
Overview
A Phase 3 trial of tegafur + gimeracil + oteracil, oxaliplatin in gastric cancer (GC). Planned start Jan 2021; status: not yet recruiting.
02
Drugs
tegafur + gimeracil + oteraciloxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04677673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04677673.